Ignite Creation Date:
2024-05-05 @ 4:36 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00278135
Status:
COMPLETED
Last Update Posted:
2014-05-19
First Post:
2006-01-13
Brief Title:
Memory Improvement With Docosahexaenoic Acid Study MIDAS
Sponsor:
DSM Nutritional Products Inc
Organization:
DSM Nutritional Products Inc
Study Overview
Official Title:
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Effects of DHA on Cognitive Functions in the Elderly
Status:
COMPLETED
Status Verified Date:
2014-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MIDAS
Brief Summary:
The purpose of this study is to investigate the effect of docosahexaenoic acid DHA 226n-3 in improving cognitive functions in subjects with age-related cognitive decline DHA is a long chain omega-3 fatty acid LC-PUFA that plays an important role in neural and visual development and cardiovascular health
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None